🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections

Recruitingn/aAges 18 Years - anyAllIstituto Ortopedico Rizzoli
NCT06887816 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the present clinical study, of prospective observational nature with biological study, is to conduct a clinical investigation on the the efficacy of a device coated with bacteriostatic silver coating, with the overall objective of understand whether the device is indeed able to reduce the number of peri-operative and post-operative infections, both early and late.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged ≥ 18 years; * Immunocompromised patients and/or diabetic patients. * Patients who have given consent Exclusion Criteria: * Patients aged \< 18 years; * Pregnant women;
💊

What it tests

  • silver coated device
  • not silver coated device
📍

Where

2 sites
Istituto Ortopedico Rizzoli
Bologna, Italy
Ospedale Mazzolani Vandini
Argenta, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy